In June 2024, Dalian Bio-Add Chemical Co., Ltd. (referred to as ‘Bio-Add Chemical’) announced that Wang Xiliang, the company’s Chief Financial Officer (CFO), has resigned from his position due to personal reasons and will no longer hold any role within the company. The board of directors expressed gratitude for Wang’s contributions during his tenure, particularly in financial management, internal controls, and capital market activities, and has already initiated the recruitment process for a new CFO to ensure a smooth transition.Bio-Add Chemical is a high-tech enterprise specializing in the research, development, production, and sale of isothiazolinone-based biocides, which are widely used in industrial water treatment, coatings, personal care products, and other sectors. As a key member of the senior management team, Wang played a significant role in strengthening the company’s financial systems, improving disclosure quality, and supporting strategic capital market initiatives. While his unexpected departure has drawn some investor attention, the company emphasized that its operations remain stable and unaffected.Industry observers note that executive changes are common among listed companies, with the critical factor being the successor’s expertise and alignment with corporate strategy. Bio-Add Chemical stated it will expedite the appointment of a new CFO and continue enhancing corporate governance and financial oversight to safeguard shareholder interests and support long-term sustainable growth.
2024年6月，大连百傲化学股份有限公司（简称“百傲化学”）发布公告称，公司财务总监王希梁因个人原因申请辞去所任职务，辞职后将不再担任公司任何职位。公司董事会对王希梁在任职期间为公司财务管理、内部控制及资本运作等方面作出的贡献表示感谢，并已启动新任财务总监的选聘程序，确保财务工作平稳过渡。百傲化学是一家专注于异噻唑啉酮类杀菌剂研发、生产和销售的高新技术企业，产品广泛应用于工业水处理、涂料、日化等多个领域。作为公司核心管理团队成员之一，王希梁自任职以来，协助公司完善财务体系，提升信息披露质量，并支持公司在资本市场上的多项重要举措。其突然离职虽引发部分投资者关注，但公司强调当前经营状况正常，财务运作有序，不会对公司日常运营造成重大影响。业内人士分析认为，高管变动在上市公司中较为常见，关键在于后续接任者的专业能力与战略协同性。百傲化学表示将尽快完成财务总监的聘任工作，并持续加强公司治理与财务管理，以保障股东利益和公司长期稳健发展。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/5506.html